Related references
Note: Only part of the references are listed.Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria
James G. Beeson et al.
FEMS MICROBIOLOGY REVIEWS (2016)
Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine
D. E. Neafsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Designing malaria vaccines to circumvent antigen variability
Amed Ouattara et al.
VACCINE (2015)
Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines
Ulrich Terheggen et al.
BMC MEDICINE (2014)
Overcoming Allelic Specificity by Immunization with Five Allelic Forms of Plasmodium falciparum Apical Membrane Antigen 1
Kazutoyo Miura et al.
INFECTION AND IMMUNITY (2013)
Erythrocyte-Binding Antigens of Plasmodium falciparum Are Targets of Human Inhibitory Antibodies and Function To Evade Naturally Acquired Immunity
Kristina E. M. Persson et al.
JOURNAL OF IMMUNOLOGY (2013)
Antibodies to Polymorphic Invasion-Inhibitory and Non-Inhibitory Epitopes of Plasmodium falciparum Apical Membrane Antigen 1 in Human Malaria
Cleopatra K. Mugyenyi et al.
PLOS ONE (2013)
Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1
Sheetij Dutta et al.
PLOS PATHOGENS (2013)
Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria
Damien R. Drew et al.
PLOS ONE (2012)
A Field Trial to Assess a Blood-Stage Malaria Vaccine
Mahamadou A. Thera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Quantifying the Importance of MSP1-19 as a Target of Growth-Inhibitory and Protective Antibodies against Plasmodium falciparum in Humans
Danny W. Wilson et al.
PLOS ONE (2011)
Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion
Prakash Srinivasan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The RON2-AMA1 Interaction is a Critical Step in Moving Junction-Dependent Invasion by Apicomplexan Parasites
Mauld Lamarque et al.
PLOS PATHOGENS (2011)
Allele Specificity of Gamma Interferon Responses to the Carboxyl-Terminal Region of Plasmodium falciparum Merozoite Surface Protein 1 by Kenyan Adults with Naturally Acquired Immunity to Malaria
Michele D. Spring et al.
INFECTION AND IMMUNITY (2010)
Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays
Danny W. Wilson et al.
MALARIA JOURNAL (2010)
The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis
Freya J. I. Fowkes et al.
PLOS MEDICINE (2010)
Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness
Danielle I. stanisic et al.
INFECTION AND IMMUNITY (2009)
Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan Adults
Arlene E. Dent et al.
MALARIA JOURNAL (2009)
Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum
Alyssa E. Barry et al.
PLOS ONE (2009)
Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity
Kwadwo A. Kusi et al.
PLOS ONE (2009)
Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development
Shannon L. Takala et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Issaka Sagara et al.
VACCINE (2009)
An Inhibitory Antibody Blocks Interactions between Components of the Malarial Invasion Machinery
Christine R. Collins et al.
PLOS PATHOGENS (2009)
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria
Faith H. A. Osier et al.
INFECTION AND IMMUNITY (2008)
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies
Kristina E. M. Persson et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Comparison of Biological Activity of Human Anti-Apical Membrane Antigen-1 Antibodies Induced by Natural Infection and Vaccination
Kazutoyo Miura et al.
JOURNAL OF IMMUNOLOGY (2008)
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children
Daniel Dodoo et al.
MALARIA JOURNAL (2008)
Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1:: Implications for vaccine design
Junhui Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Apical membrane antigen 1: a malaria vaccine candidate in review
Edmond J. Remarque et al.
TRENDS IN PARASITOLOGY (2008)
Recent insights into humoral and cellular immune responses against malaria
James G. Beeson et al.
TRENDS IN PARASITOLOGY (2008)
Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa
Issa Nebie et al.
INFECTION AND IMMUNITY (2008)
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3
Christian Roussilhon et al.
PLOS MEDICINE (2007)
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
Alassane Dicko et al.
PLOS ONE (2007)
Profiling the antibody immune response against blood stage malaria vaccine candidates
Julian C. Gray et al.
CLINICAL CHEMISTRY (2007)
Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies
Kristina E. M. Persson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket
T Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya
K Chelimo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1
A Cortes et al.
INFECTION AND IMMUNITY (2005)
Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum
J Healer et al.
MOLECULAR MICROBIOLOGY (2004)
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria
SD Polley et al.
VACCINE (2004)
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1):: Production and activity of an AMA1 vaccine and generation of a multiallelic response
MC Kennedy et al.
INFECTION AND IMMUNITY (2002)
High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion
CHM Kocken et al.
INFECTION AND IMMUNITY (2002)
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea
B Genton et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Specificity of the protective antibody response to apical membrane antigen 1
AN Hodder et al.
INFECTION AND IMMUNITY (2001)
Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species
T Triglia et al.
MOLECULAR MICROBIOLOGY (2000)
Share Paper
